Director, Patient Centred Outcomes (Oncology)

Location: Remote/home-based; listed locations include Cambridge, Cambridgeshire, UK, London, UK, and California, US.

Salary: US-based candidates: $212,000–$318,000 base pay, plus potential bonus, equity, and benefits.

Company

hirify.global is a global biopharmaceutical company developing medicines for serious diseases, with a portfolio focused on sleep disorders, epilepsy, oncology, and neuroscience.

What you will do

• Lead patient-centered evidence strategies for neuro-oncology and solid-tumor oncology launches, lifecycle expansions, and registrational programs.
• Build early-phase COA roadmaps, disease conceptual models, and measurement strategies aligned with Target Product Profiles.
• Develop regulatory strategies, briefing documents, clinical summaries, COA dossiers, and evidence supporting product-label claims with FDA, EMA, and other health authorities.
• Oversee concept elicitation, cognitive debriefing, psychometric validation, translatability assessments, and COA integration into protocols, SAPs, and CSRs.
• Direct global eCOA/ePRO implementation, including licensing, translation and linguistic validation across 40+ countries, electronic migration testing, and investigator training.
• Collaborate with Medical Affairs, Commercial, Pricing and Market Access, Biostatistics, Clinical Operations, Patient Advocacy, and external scientific partners while mentoring junior PCO scientists and fellows.

Requirements

• Master’s degree in Psychometrics, Health Outcomes Research, Health Economics, Epidemiology, Public Health, Behavioral Sciences, Psychology, or a related quantitative or clinical discipline; or a doctoral degree such as PhD, PharmD, or MD. A doctoral degree is strongly preferred.
• 8–10+ years of dedicated experience in Patient-Centered Outcomes, Clinical Outcome Assessments, Patient-Reported Outcomes, or HEOR within a global biopharmaceutical company or specialized consultancy.
• Demonstrated success with COA/PRO strategies for commercial launches, registrational oncology filings, or major lifecycle expansions in solid tumors and/or neuro-oncology.
• Direct experience authoring regulatory briefing documents, engaging FDA, EMA, and PMDA, and applying FDA PFDD guidance to support label claims and review procedures.
• Strong command of psychometric evaluation, mixed-methods research, qualitative interviewing, and questionnaire development and validation.
• Deep understanding of patient-reported evidence in payer requirements, HTA methodologies including EU JCA, NICE, CADTH, and ICER, and commercial value narratives.
• Hands-on experience directing global eCOA/ePRO trial operations, vendor management, and protocol integration.
• Exceptional communication and presentation skills, including the ability to explain complex psychometric data and strategic rationales to executives, commercial stakeholders, and regulatory panels.

Culture & Benefits

• Remote/home-based work arrangement is listed for the role.
• Opportunity to work across global oncology, neuroscience, clinical development, regulatory, market access, and patient advocacy programs.
• Benefits for eligible US-based employees include medical, dental and vision insurance, a 401(k) retirement savings plan, and flexible paid vacation.
• Potential eligibility for discretionary annual cash bonus or incentive compensation and long-term equity grants.
• hirify.global is an equal opportunity and affirmative action employer.